Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    All NSAIDs raise post-MI risk but some are safer than others: Next chapter

    August 5, 2020

    A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen for some of the drugs are real.

  • 1
    News

    ACC panel defines, advises on heart failure with ‘recovered’ EF

    August 5, 2020

    An American College of Cardiology expert panel has issued a definition of heart failure with recovered ejection fraction and recommendations for diagnosis and treatment.

  • 1
    News

    Early palliative care fails to improve QOL in advanced heart failure

    August 3, 2020

    “My first reaction is disappointment. We had hoped to see the ENABLE program, which had been successful in cancer, translate to the heart failure setting.”

  • 1
    News

    Heart damage even after COVID-19 ‘recovery’ evokes specter of later heart failure

    July 31, 2020

    Recovery from acute COVID-19 isn’t necessarily the end of it, clearly. Two reports aim to clarify how SARS-CoV-2 can directly invade the heart and indirectly cause persisting myocardial injury.

  • 1
    News

    Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

    July 29, 2020

    The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.

  • 1
    News

    MIS-C is a serious immune-mediated response to COVID-19 infection

    July 28, 2020

    Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.

  • 1
    News

    COVID-19 fears would keep most Hispanics with stroke, MI symptoms home

    July 27, 2020

    Survey: Hispanics are significantly more likely than Blacks or Whites to be afraid to go to the hospital for a heart attack or stroke.

  • 1
    News

    Cleaner data confirm severe COVID-19 link to diabetes, hypertension

    July 27, 2020

    Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links.

  • 1
    News

    Ultrasound, cardiac CT valuable in COVID-19 assessment

    July 27, 2020

    An expert panel of the American College of Cardiology offers evidence-based guidance for evaluating cardiac complications of COVID-19 infections.

  • News

    Low-dose prasugrel preserves efficacy but lowers bleeding in elderly

    July 23, 2020

    In an ISAR-REACT 5 substudy of elderly ACS patients, low-dose prasugrel was favored over ticagrelor.

Previous1 … 27 28 29 30 31 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences